만성 B형 간염 환자에서 Pegylated 인터페론 알파2a 치료 중 발생한 원형 탈모

초록

Recent studies recommend pegylated interferon alpha2a as the first choice treatment for chronic hepatitis B,especially when the patient is negative for HBeAg. Pegylated interferon alpha is known to show variable side effectsincluding skin symptoms, with alopecia as the most common dermatologic side effect experienced for 10% up to36%. pcc) Most alopecia cases related to pegylated interferon alpha were presented with telogen effluvium pattern,but alopecia areata cases are reported rarely. In this case, typically localized alopecia areata was presented withpegylated interferon alpha2a treatment in hepatitis B patient, and the course of alopecia areata seemed to be relatedwith administration and discontinuation of pegylated interferon alpha2a.

키워드